Stocks Comparison
Myriad Genetics vs Alpha Teknova: revenue, profit, margins and growth compared
Myriad Genetics brought in $824.5M of revenue in fiscal 2025, Alpha Teknova $40.5M in fiscal 2025. Revenue changed by -1.6% at Myriad Genetics and +7.4% at Alpha Teknova on the year before, so Alpha Teknova grew faster. Myriad Genetics kept -44.4% of its revenue as net profit, Alpha Teknova -42.6%.
Side by side, latest fiscal year
| MYGN | TKNO | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $824.5M | $40.5M |
| Revenue growth | -1.6% | +7.4% |
| Net income | -$365.9M | -$17.3M |
| Net margin | -44.4% | -42.6% |
| Free cash flow | n/a | -$9.8M |
| Free cash flow margin | n/a | -24.2% |
| Earnings per share (diluted) | -$3.95 | -$0.32 |
| Cash | $149.6M | $5.9M |
| Debt | $119.9M | $13.1M |
| Price to earnings | n/a | n/a |
| Market value | $398.9M | $500.9M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #159 of 523 · Health care | #376 of 523 · Health care |
Over the years
Questions about Myriad Genetics and Alpha Teknova
Which is bigger by revenue, Myriad Genetics or Alpha Teknova?
Myriad Genetics is bigger by revenue: $824.5M in fiscal 2025, against $40.5M for Alpha Teknova in fiscal 2025.
Which keeps more of its revenue as profit, Myriad Genetics or Alpha Teknova?
Myriad Genetics had a net margin of -44.4% in fiscal 2025; Alpha Teknova had -42.6% in fiscal 2025.
Which grew revenue faster, Myriad Genetics or Alpha Teknova?
In their latest fiscal years revenue changed by -1.6% at Myriad Genetics and +7.4% at Alpha Teknova.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.